The current selling price of regorafenib in the Chinese market
Regorafenib, this important anti-cancer drug, has been officially launched in China and has been included in the medical insurance system, which undoubtedly brings great convenience and financial support to patients. Recent market prices show that the selling price of regorafenib in China is generally around four to five thousand yuan. Please note, however, that this price is not fixed and may fluctuate depending on region, point of sale and time of day.
In order to ensure the most accurate price information and medical insurance reimbursement details, patients are advised to consult their local hospital pharmacy for detailed consultation before purchasing. In addition, in addition to the domestic market, foreign original and generic drugs of Regorafenib are also one of the choices for patients.
The original drug is mainly sourced from Türkiye, and the price is slightly higher, about more than one thousand yuan. Generic drugs mostly come from countries such as Laos, India, and Bangladesh, and their prices range from a few hundred yuan to more than a thousand yuan. It is important to make it clear that whether it is an original drug or a generic drug, the core drug ingredients are similar, so there is no significant difference in the therapeutic effect.
When choosing regorafenib, patients should not only consider the price, but also pay attention to the source, quality and reputation of the manufacturer. When purchasing domestically, priority should be given to drugs imported through formal channels to ensure the safety and effectiveness of the drugs. If you consider purchasing foreign drugs, you also need to do so through formal channels and trustworthy suppliers to avoid purchasing substandard or counterfeit products.
In summary, the popularity of regorafenib in the Chinese market and the coverage of medical insurance have provided patients with more treatment options and benefits. When purchasing, patients should make informed choices based on their personal circumstances and needs, and seek advice and guidance from medical professionals before purchasing.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)